Back to Search Start Over

Protective effects of L-glutamine against toxicity of deltamethrin in the cerebral tissue.

Authors :
Varol, Sefer
Özdemir, Hasan Hüseyin
Çevik, Mehmet Uğur
Altun, Yaşar
Ibiloğlu, Ibrahim
Ekinci, Aysun
Ibiloğlu, Aslıhan Okan
Balduz, Metin
Arslan, Demet
Tekin, Recep
Aktar, Fesih
Aluçlu, Mehmet Ufuk
Source :
Neuropsychiatric Disease & Treatment; Apr2016, Vol. 12, p1005-1011, 7p
Publication Year :
2016

Abstract

Background: Deltamethrin (DLM) is a broad-spectrum synthetic dibromo-pyrethroid pesticide that is widely used for agricultural and veterinary purposes. However, human exposure to the pesticide leads to neurotoxicity. Glutamine is one of the principal, free intracellular amino acids and may also be an antioxidant. This study was undertaken in order to examine the neuroprotective and antioxidant potential of L-glutamine against DLM toxicity in female Wistar albino rats. Materials and methods: The rats were divided into the following groups (n=10): Group I: control (distilled water; 10 mL/kg, po one dose), Group II: L-glutamine (1.5 g/kg, po one dose), Group III: DLM (35 mg/kg, po one dose), and Group IV: DLM (35 mg/kg, po one dose) and L-glutamine (1.5 g/kg, po one dose after 4 hours). Total oxidant status (TOS), total antioxidant status (TAS), tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 levels and apoptosis were evaluated in brain tissue. Results: DLM-treated animals had a significant increase in brain biochemical parameters, as well as TOS and TAS. Furthermore, the histopathological examination showed neuronal cell degeneration in the cerebral tissue. L-Glutamine treatment decreased the elevated brain levels of TOS and neuronal cell degeneration. There was no difference in tumor necrosis factor-α, IL-1β, and IL-6 levels between the groups. Conclusion: L-Glutamine may reduce the toxic effects of DLM in the cerebral tissue through antioxidant properties. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
11766328
Volume :
12
Database :
Complementary Index
Journal :
Neuropsychiatric Disease & Treatment
Publication Type :
Academic Journal
Accession number :
115361480
Full Text :
https://doi.org/10.2147/NDT.S104011